2025 Communication Drug Development 
Viseven
JANUARY 4, 2023
This article will cover the most important areas of AI influence on the pharma industry and new drugs development. From life-saving drugs discovery, development, and production to clinical trials, communication, and drug target identification — AI pharmaceutical is a definite game-changer.
Putting Patients First Blog
MAY 29, 2024
We believe in the power of high-quality patient engagement that is characterized by sustained, reciprocal communication between patients and decision- makers. The NHC urges CMS to engage collaboratively with MA plans to track the clarity, accuracy, and transparency of marketing materials and communications.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 19, 2022
“In a situation where most of the development of treatments in Korea is mostly centred on cancer and metabolic diseases, I noticed that there weren’t any companies that were focusing on sensory diseases.”. Kim says the Dry Eye Disease market is large and growing, with analysts predicting it will hit $6 billion USD by 2025. Conclusion.
FDA Law Blog: Biosimilars
JULY 9, 2024
FDA strongly encourages sponsors to discuss plans for a waiver early in the planning stages of the study or development program. If FDA determines that a waiver will be issued, it may consider public communications about the decision. Some unanswered questions remain.
Putting Patients First Blog
APRIL 14, 2023
10: External Data Submission Timing The NHC understands the tight timeline for the drug selection and price negotiation processes. Including this information in the explanation will help patient advocates develop the most useful data for future negotiations. He is reachable via e- mail at egascho@nhcouncil.org. Sincerely, Randall L.
Pharmaceutical Technology
MAY 30, 2023
The company believes this approach has the potential to revolutionise drug discovery in therapeutic areas with unclear mechanisms or limited success using traditional methods. AI has already proven a boon in other areas of drug development in recent years with the Covid-19 pandemic motivating innovation.
Pharmaceutical Technology
MAY 30, 2023
The company believes this approach has the potential to revolutionise drug discovery in therapeutic areas with unclear mechanisms or limited success using traditional methods. AI has already proven a boon in other areas of drug development in recent years with the Covid-19 pandemic motivating innovation.
Expert insights. Personalized for you.
52 
Let's personalize your content